Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Acido Acetilsalicilico Teva Italia 100 mg compresse gastroresistenti
DRUG
2 trials
Sponsors
Fondazione IRCCS Istituto Nazionale Dei Tumori
Conditions
Patients scheduled for major surgery for oncologic indication
Phase 2
Targeting inflammation to reduce 90-day and 1-year postoperative severe morbidity in patients with unfavorable inflammatory profile undergoing oncologic surgery (POST CARE Trial)
Not yet recruiting
CTIS2024-515333-14-03
Fondazione IRCCS Istituto Nazionale Dei Tumori
Patients scheduled for major surgery for oncologic indication
Target: 83
Updated: 2025-12-17
Phase 3
Targeting inflammation to reduce 90-day and 1-year postoperative severe morbidity in patients with unfavorable inflammatory profile undergoing oncologic surgery (POST-CARE trial)
Withdrawn
CTIS2024-515333-14-00
Fondazione IRCCS Istituto Nazionale Dei Tumori
Patients scheduled for major surgery for oncologic indication
Target: 444
Updated: 2025-02-07